10715 Double R Boulevard
MD Labs was founded in 2011 with the goal to specialize in prescription monitoring toxicology and serve physicians across the United States. Our founders, Matthew Rutledge and Denis Grizelj started the company with the goal of creating a more provider-friendly testing service that prides itself on delivering prompt, accurate, reliable and easy to understand results. Employing state of the art technology and testing for a wide array of analytes, our team of PhDs and clinical technologists is able to keep ahead of the needs of our community. Constantly adding services based on client requests and pharmacotherapeutic trends allows us to provid quick, accurate, and cost-effective drug testing while enhancing patients’ prescription adherence and overall patient care. In 2014, MD Labs began offering pharmacogenetic (PGX) testing as a way for providers to better understand individual patients responses to prescription medications and reduce adverse drug reactions.
Founders: Matthew Rutledge and Denis Grizelj
Chief Scientific Advisor: Teri E. Klein